Central Sensitization, Explained for the Person Living With It

If a doctor labeled you with central sensitization and you walked out of that appointment more confused than before, this page is for you. If your imaging looks normal but your pain doesn't quit, this page is for you. If you've collected diagnoses across body systems (back pain plus IBS, migraines plus fibromyalgia, TMJ plus pelvic pain) and no one has connected them, this page is for you.

What you're going to read is not a clinical handout. It's the comprehensive explanation written for the person living with the thing, by someone who has spent three years reading the research.

First, the part most articles get wrong

If you've been told your tests look normal so the pain must not be that bad, this is the section your doctor should have read first.

Normal tests don't mean imaginary pain. They mean the tests are looking in the wrong place.

Standard imaging (X-ray, MRI, CT) shows tissue. Tissue is not where central sensitization lives. Central sensitization lives in the nervous system's processing of signals, and that doesn't show up on a structural scan. It shows up on functional MRI, which most patients never get because insurance won't pay for it. It shows up on quantitative sensory testing, which is a research tool, not a clinic tool. The result: your scan came back clean and you got told to manage stress, when what was actually happening was a measurable, real, brain-level change in how you process sensation.

The field of pain medicine has been working through this for decades. In 2017, the International Association for the Study of Pain formally recognized nociplastic pain as the third mechanism of chronic pain, alongside nociceptive (tissue-based) and neuropathic (nerve-injury-based). Central sensitization is the most-studied mechanism inside the nociplastic category. Kosek and colleagues published the formal clinical grading criteria in Pain in 2021. This isn't fringe. It's the official taxonomy.

Brain-imaging studies confirm the finding. Patients with chronic pain show measurable changes in the anterior insula, the anterior midcingulate cortex, and the periaqueductal gray. These structures fire in the presence of real-time tissue injury and they fire in chronic pain when no injury is present. The pattern is the same. Your brain is running a real protection program. The program just got stuck.

Here's the part that matters. If a clinician treated your pain as imaginary because your tests came back clean, the clinician was working with an outdated model. The model the field actually uses now says your pain is real, the cause is in the central nervous system's interpretation of signals, and that's a category of pain with its own treatment evidence. Nothing about that diagnosis means weak. Nothing about it means making it up. It means your nervous system learned to amplify, and amplification is something we know how to address.

What central sensitization actually is, in plain language

Your nervous system has a volume control for pain.

After an injury, the volume gets turned up so you pay attention to the danger. That's useful. Sprain an ankle, the volume goes up, you stop running on it. Cut a finger, the volume goes up, you keep your hand still while it heals. The system is doing exactly what it evolved to do.

In central sensitization, the volume knob gets stuck on high. Long after the original injury heals, your nervous system keeps amplifying. Normal signals from movement, touch, or pressure get turned up into pain. Things that used to be neutral now hurt. This is not your imagination. The amplification is happening at the level of spinal cord neurons, brainstem circuits, and cortical processing.

Clifford Woolf, working in Pat Wall's lab at University College London, was the first to prove it. In 1983 he published a paper in Nature showing that inflammatory injuries in rats produced enhanced responsiveness in surrounding undamaged tissue. The critical experiment: he blocked the original injury with a peripheral anesthetic. The expanded sensitivity did not collapse. The central nervous system itself had changed. Pain from the original injury was being maintained without input from the original injury. That single experiment is the foundation of modern pain neuroscience.

Woolf and Tim Salter expanded the framework in a landmark 2000 paper in Science titled 'Neuronal plasticity: increasing the gain in pain.' The volume-knob metaphor sits on top of that paper. Your nervous system turns up the gain on pain signals. In central sensitization, it forgets to turn the gain back down.

In 2003, Ru-Rong Ji, Woolf, and colleagues published a Trends in Neurosciences paper that quietly changed everything. They showed pain and memory share the same cellular machinery. Long-term potentiation, the same molecular process that lets you remember a phone number, is the process your nervous system uses to learn pain. NMDA receptors. Calcium influx. ERK phosphorylation. Same cascade. This isn't a metaphor. Pain literally uses the brain's learning system.

Three things this explains that probably confused you before.

One, your pain spreads. The amplification reaches further parts of the nervous system over time. What started in your lower back now includes your hip and the back of your thigh. What started in one jaw joint now affects your neck and shoulders. The pain didn't move to a new injury. The amplification expanded the receptive field, a phenomenon Woolf documented in his original 1983 paper.

Two, your pain is worse when you're stressed, exhausted, or under-slept. The volume knob is sensitive to nervous-system state. When the system is taxed, the gain goes up. Schuh-Hofer and colleagues showed in 2013 that one night of sleep deprivation alone is enough to produce the laboratory profile of central sensitization in healthy people. You aren't imagining the bad-day flares. The mechanism is measurable.

Three, things that shouldn't hurt sometimes hurt. A breeze on the skin. Light pressure from clothing. The temperature of shower water. Or movements that used to be fine become painful out of proportion to what should be a neutral input. The clinical names are allodynia (pain from non-painful stimuli) and hyperalgesia (exaggerated pain from mildly painful stimuli). Both are textbook signs of central sensitization.

The mechanism, summarized in one line. The pain signal isn't the problem. The amplification setting is. Real signals plus stuck volume equals real pain that's out of proportion to the input. If this is starting to sound like your pain, the self-screener tells you whether your specific pattern fits.

How to recognize central sensitization in your own pain

Central sensitization shows up in patterns. Not all patterns will fit you. If you check three or more of the items below, the central sensitization explanation is worth taking seriously and worth talking through with a clinician familiar with the diagnosis. Howard Schubiner, a clinical professor at Michigan State, has documented in a 2024 analysis that 88.3% of chronic back and neck pain meets criteria consistent with the same family of mechanisms. The pattern recognition is real, not novelty.

Conditions where central sensitization is the main story

Central sensitization isn't a separate disease. It's a mechanism that shows up across a family of conditions that look unrelated at first glance. Once you see it, the comorbidity patterns make sense.

Chronic back pain. The strongest evidence base in the entire field. Maher and colleagues in The Lancet (2017) estimated that 85% of chronic back pain has no identifiable structural cause. The Boulder Back Pain Study (Ashar et al., JAMA Psychiatry, 2022, n=151) showed 66% of chronic back pain patients became pain-free or nearly pain-free in four weeks of Pain Reprocessing Therapy, a treatment built around retraining the central sensitization pattern. We've written the full guide at neuroplastic pain.

Fibromyalgia. The IASP classifies fibromyalgia as the prototypical nociplastic pain condition, meaning central sensitization is the mechanism that defines it (Kosek et al., 2021). Lumley and Schubiner's 2017 cluster-randomized trial in PAIN (n=230) compared Emotional Awareness and Expression Therapy to CBT and education. EAET produced a 22.5% rate of 50% pain reduction versus 8.3% for CBT. We've written the comprehensive fibromyalgia guide for the patient version of the science. Sarah's recovery story is the practical version.

TMJ and jaw pain. La Touche and colleagues (2018) documented remote-body-site pressure-pain sensitivity in chronic TMD with a standardized mean difference of -1.92, evidence of widespread central sensitization rather than a local jaw problem. The 2023 BMJ network meta-analysis by Yao and colleagues pooled 153 trials and 8,713 patients across 59 interventions and recommended against surgery and irreversible dental procedures, recommending CBT plus biofeedback as the strong-evidence option. We've written the comprehensive TMJ guide that covers what central sensitization means specifically for chronic jaw pain. Jenna's TMJ recovery story walks through that path.

IBS. The Rome Foundation reclassified IBS as a disorder of gut-brain interaction. Gut-directed hypnotherapy, which targets the same central sensitization mechanism through hypnosis-assisted reattribution, has the strongest evidence base in adult IBS. A recent meta-analysis found all twelve included trials reported benefit over control, with a pooled effect size around 0.73. Anna's IBS recovery story is the practical version.

Migraines and vestibular migraine. Central sensitization is documented in 60 to 90% of chronic migraine patients, presenting clinically as cutaneous allodynia (the scalp hurting to brush, the face hurting to wash). The American Academy of Neurology gives biofeedback a Grade A recommendation for migraine prevention. Mei's vestibular migraine recovery story is the example of a vestibular PT who recovered without medication.

Sciatica and persistent leg pain. About 25% of chronic low back pain and chronic sciatica meets the criteria for central sensitization. Disc bulges are extremely common in pain-free people. Brinjikji and colleagues at Mayo Clinic (AJNR, 2015) pooled 33 imaging studies of 3,110 pain-free individuals and found disc bulges in 30% of pain-free 20-year-olds, with rates climbing into the 80s by age 80. Peul and colleagues' Dutch trial in NEJM (2007) found 56% of sciatica patients recovered fully without surgery. We've written the comprehensive sciatica guide for the patient version of the science, and Kenji's sciatica recovery is the example of post-surgical persistent pain that resolved with nervous-system retraining.

Muhammad Yunus called this family of conditions Central Sensitivity Syndromes back in 2007. The comorbidity numbers explain why he saw a family rather than a list of separate disorders: 78% of chronic temporomandibular disorder patients have at least one comorbid pain condition (Slade, 2020), the fibromyalgia-TMJ overlap odds ratio is 19.7, and fibromyalgia-IBS comorbidity runs 32 to 80% across studies. Multiple co-occurring pain conditions across different body systems are themselves evidence of a shared central mechanism, not separate problems to chase one at a time.

Can central sensitization be reversed?

Yes.

The same neuroplasticity that created the amplified pain pattern allows it to be unlearned. The Boulder Back Pain Study (Ashar et al., JAMA Psychiatry, 2022) showed 66% of chronic back pain patients became pain-free or nearly pain-free in four weeks of Pain Reprocessing Therapy. The follow-up paper, published in JAMA Network Open in 2023, traced the mechanism: reattribution of pain to mind-brain processes was the key mediator. Before PRT, only 10% of patients held a mind-brain attribution for their pain. After PRT, 51% did. The conviction itself was the active ingredient.

This is the most important paragraph on this page. If you take nothing else away, take this. Central sensitization is reversible because it's a learning, not damage. Anything your nervous system learned can be unlearned. The brain that turned the volume up can turn the volume back down. The molecular machinery that supports central sensitization (NMDA receptor activation, AMPA trafficking, glial cell signaling) is plastic in both directions. The pattern Woolf described in 1983 doesn't have to be permanent.

The evidence base reaches beyond back pain.

For fibromyalgia, Lumley and Schubiner's 2017 EAET trial showed clinically significant pain reduction at rates roughly 2.7 times higher than CBT. Yarns and colleagues' 2024 JAMA Network Open trial of older veterans replicated the effect with a 63% response rate for EAET versus 17% for CBT. EAET targets the emotional drivers that keep the central sensitization pattern active and outperforms a strong cognitive control, which is itself an active treatment.

For complex regional pain syndrome, mirror therapy and graded motor imagery target the cortical reorganization underlying central sensitization. Number-needed-to-treat estimates from Lorimer Moseley's work cluster around 2, which in pain medicine is exceptional.

For chronic neck pain, Nijs and colleagues' 2025 JAMA trial on pain neuroscience education showed neck disability reduced by 33% versus 16% for usual care, with the effect holding at 12 months. Disability cut roughly in half from education that targets the central sensitization model itself.

Louw and colleagues' 2016 systematic review found pain neuroscience education produces meaningful effect sizes on kinesiophobia, catastrophizing, and disability across multiple chronic pain populations. Education isn't placebo. It's a real therapeutic intervention because it changes the brain's threat assessment, which is the upstream driver of the central sensitization pattern.

Brain imaging confirms the changes are physical, not just self-report. PRT produced measurable quieting of the anterior insula and the anterior midcingulate cortex in the Boulder trial. Seifert and Maihofner reviewed the broader literature in 2011 and concluded that gray matter volume, cortical thickness, and white matter integrity changes from chronic pain are reversible when treatment works. Your brain physically changes in chronic pain. It physically changes back when the central sensitization pattern resolves.

The honest caveat that most pages skip. None of these treatments work for everyone. The patients who respond best are the ones who reach genuine belief that their pain is neuroplastic, that their tissue is sound, that the amplification can come back down. Conviction is the active ingredient because conviction is what changes the prediction the brain is generating. People who finish a treatment course saying 'I learned a lot but I'm not sure I believe it' tend to plateau. People who finish saying 'this is what's been happening to me, the science fits, I can work with this' tend to keep improving. That's not motivational language. It's the mediation analysis from the Boulder follow-up paper, in plain English.

One implication. If you've already read about central sensitization, intellectually agree, and still hurt, the gap is conviction depth, not new information. The next move is daily practice that builds that conviction in your own body, not another article.

What actually treats central sensitization

Five approaches have serious evidence behind them. They're not competing schools. They're different angles on the same goal: bringing the nervous system's amplification setting back down.

1. Pain Reprocessing Therapy (PRT). The strongest evidence base in the field for chronic primary pain. Developed by Alan Gordon and tested in the Boulder Back Pain Study (Ashar et al., JAMA Psychiatry, 2022). PRT teaches you to reinterpret pain sensations through a lens of safety rather than danger. The core practice is somatic tracking: turning your attention toward the sensation, observing it with curiosity instead of fear, and giving your brain new information about what the signal actually means. The mediation analysis (Ashar et al., JAMA Network Open, 2023) confirmed reattribution to mind-brain processes was the active mechanism. Best-fit population: chronic back pain, neck pain, and other primary musculoskeletal pain where structural causes have been ruled out. Read the complete PRT guide.

2. Emotional Awareness and Expression Therapy (EAET). Strongest evidence in fibromyalgia and in older adults. Developed by Mark Lumley and Howard Schubiner. EAET targets the emotional drivers (often unprocessed anger, grief, or fear from past adversity) that keep the central sensitization pattern active. In the Yarns 2024 trial of older veterans, EAET produced 63% clinically significant pain reduction versus 17% for CBT. The Lumley 2017 fibromyalgia trial showed similar separation. Best-fit population: fibromyalgia, central sensitivity syndromes with strong stress or trauma history, patients for whom CBT-style cognitive reframing has plateaued.

3. Pain Neuroscience Education (PNE). Most cost-effective intervention in the field. Adriaan Louw's 2016 systematic review pooled the literature and found medium-to-large effect sizes on kinesiophobia and catastrophizing. Nijs and colleagues' 2025 JAMA neck pain trial cut disability roughly in half at 12 months using PNE alone. The mechanism is direct: teaching people that their pain is real but not dangerous reduces the brain's threat assessment, which reduces central sensitization output. Education is treatment. Not placebo, not adjunct, treatment. PNE is most powerful when paired with movement so the new understanding gets embodied, not just intellectualized.

4. Graded movement and graded exposure. Counterintuitively, lower-intensity movement at a preferred pace tends to outperform high-intensity rehabilitation for sensitized populations. The reason is fear avoidance. Vlaeyen and Linton's 2000 fear-avoidance model (Pain, cited over 5,000 times) describes how pain becomes paired with movement contexts through classical conditioning. The chair, the bed, the gym all become predicted-pain environments, and the prediction itself drives the signal. Graded exposure breaks the pairing. Den Hollander and colleagues have run multiple trials showing graded exposure outperforms protective avoidance for central sensitization populations.

5. Sleep, stress regulation, and the autonomic baseline. This is the foundation under everything else. Schuh-Hofer and colleagues showed in 2013 that one night of sleep deprivation alone produces the laboratory profile of central sensitization in healthy people. Krause and colleagues (Journal of Neuroscience, 2019) found sleep deprivation increases somatosensory cortex pain responses by 120% while reducing the brain's pain-dampening systems by 60 to 90%. If your sleep is broken, central sensitization is being reinforced every night and only partially undone every morning. Sleep is not optional infrastructure. It's the condition under which the other treatments can work. Stress regulation runs on the same logic. Chronic autonomic activation drives glial cell signaling that maintains central sensitization, so practices that downregulate the autonomic baseline (slow breathing, vagal tone work, grief processing, time outdoors) reduce the substrate that holds the pattern in place.

Medications have a role and a limit. SNRIs (duloxetine, milnacipran) and low-dose naltrexone reduce central sensitization markers in some patients and can take the edge off while you do the nervous-system work. The limit: medications don't reverse the underlying pattern. They modulate the output. The conviction that drives the Boulder trial results doesn't come from a pill. Talk to your prescriber before changing anything about your medication regimen.

Where PainApp fits. PainApp is the self-guided application of these methods. The AI Pain Coach uses the same reattribution mechanism the Boulder trial validated, applied in real time to whatever you're feeling that morning. The condition-specific courses convert somatic tracking and graded exposure into ten-minute daily routines for your specific condition. The F.I.T. Pain Tracker runs Schubiner's clinical framework as a daily tool you can watch your own pattern through. None of this replaces a PRT-certified therapist if you can find and afford one. It is the daily rehearsal piece that, in every trial cited on this page, was the part that actually worked. Talk to your healthcare provider before changing any aspect of your current treatment.